Fosun Pharma Buys Alma Lasers

Fosun Pharma plans to continue its strategy of moving from product distribution to R&D and manufacturing, and gain a leading position in the international aesthetic medical device market segment.

Alma Lasers is an energy based (light, laser, radio frequency, and ultrasound) device manufacturer, with a comprehensive product offering and international sales network. Alma Lasers has developed world-class R & D capabilities in medical and cosmetic energy-based devices, as well as a leading brand name, recording nearly USD 100 million dollars total revenue in 2012; according to independent third-party research, the company has an overall 15% market share in the global high-end esthetic energy-based device segment.

“We are very optimistic about the growth prospects of the global medical and cosmetic energy-based device market, especially in the Brazil, Russia, India, and China, as well as other emerging markets,” said Qiyu Chen, chairman of Fosun Pharma. “Fosun Pharma will build on Alma's strength and be committed to developing a high-end medical device research, manufacturing platform. The acquisition demonstrates Fosun Pharma’s strategy in pursuit of global expansion.”

“Fosun's successful international M&A experience and strategic focus on healthcare and aesthetic and medical devices provide Alma Lasers with an exceptional platform to grow our business in Asia and globally,” said Ziv Karni, CEO of Alma Lasers. “We look forward to working with the management team of Fosun and benefiting from their expertise.”

Related Links:
Fosun Pharma
Alma Lasers